(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-03 View latest technical analysis
10 day averaged volume of Adaptimmune Therapeutics is 1363959
| Date | Daily Closing Price | Open | High | Low | Volume |
| 03 Tue Sep 2024 | 1.21 | 1.24 | 1.32 | 1.20 | 0.915 times |
| 30 Fri Aug 2024 | 1.27 | 1.26 | 1.28 | 1.21 | 0.722 times |
| 30 Fri Aug 2024 | 1.27 | 1.26 | 1.28 | 1.21 | 0.723 times |
| 29 Thu Aug 2024 | 1.27 | 1.24 | 1.31 | 1.21 | 0.823 times |
| 28 Wed Aug 2024 | 1.22 | 1.25 | 1.25 | 1.17 | 0.926 times |
| 27 Tue Aug 2024 | 1.24 | 1.30 | 1.33 | 1.22 | 0.89 times |
| 26 Mon Aug 2024 | 1.33 | 1.23 | 1.33 | 1.20 | 1.239 times |
| 23 Fri Aug 2024 | 1.21 | 1.16 | 1.23 | 1.16 | 0.773 times |
| 22 Thu Aug 2024 | 1.17 | 1.19 | 1.26 | 1.17 | 0.991 times |
| 21 Wed Aug 2024 | 1.19 | 1.08 | 1.19 | 1.08 | 1.394 times |
My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 1.2, but if it comes below 1.2, then a intra day sell could be more profitable.
If you take a sell trade below 1.2, then use 1.2 as stoploss and 1.14 as target. However if you take a buy trade in stock , then use 1.2 as stoploss and 1.4 as target.
Share price targets for Adaptimmune Therapeutics (ADAP)
| Target Type | Value |
| Downside Target | 0.83 |
| Downside Target | 0.94 |
| Downside Target | 0.98 |
| Downside Target | 1.00 |
| Downside Target | 1.02 |
| Downside Target | 1.15 |
| Upside Target | 1.26 |
| Upside Target | 1.32 |
| Upside Target | 1.33 |
| Upside Target | 1.34 |
| Upside Target | 1.36 |
| Upside Target | 1.48 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
| Target Type | Value |
| Downside Intraday Target | 1.17 |
| Downside Intraday Target | 1.12 |
| Upside Intraday Target | 1.29 |
| Upside Intraday Target | 1.36 |
| Upside Intraday Target | 1.24 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 03 Tue Sep 2024 | 1.21 | 1.24 | 1.32 | 1.20 | 1.267 times |
| 30 Fri Aug 2024 | 1.27 | 1.26 | 1.28 | 1.21 | 0.157 times |
| 30 Fri Aug 2024 | 1.27 | 1.23 | 1.33 | 1.17 | 0.835 times |
| 23 Fri Aug 2024 | 1.21 | 1.08 | 1.26 | 1.02 | 0.776 times |
| 16 Fri Aug 2024 | 1.08 | 1.08 | 1.19 | 1.00 | 0.887 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 03 Tue Sep 2024 | 1.21 | 1.24 | 1.32 | 1.20 | 0.024 times |
| 30 Fri Aug 2024 | 1.27 | 1.33 | 1.36 | 0.94 | 1.214 times |
| 31 Wed Jul 2024 | 1.33 | 1.00 | 1.48 | 0.98 | 1.232 times |
| 28 Fri Jun 2024 | 0.97 | 1.10 | 1.15 | 0.83 | 0.953 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term and the buy signal is strong.
Adaptimmune Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.24 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term and the buy signal is strong.
Adaptimmune Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.24 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.